Melinta Therapeutics Inc (MLNTQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -74 | -73,932 | -86,523 | -54,211 | -29,406 |
| Depreciation Amortization | 114 | 497 | 84 | 59 | 30 |
| Accounts receivable | -2,623 | 43 | 3,108 | 3,608 | 3,793 |
| Accounts payable and accrued liabilities | 1,342 | -21 | 2,896 | 4,899 | 1,557 |
| Other Working Capital | 1,734 | -3,171 | 7,669 | 7,258 | 2,835 |
| Other Operating Activity | 3,072 | 6,004 | 1,514 | -3,467 | -2,985 |
| Operating Cash Flow | $3,565 | $-70,580 | $-71,252 | $-41,854 | $-24,176 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -109 | -463 | -9 | -9 | N/A |
| Investing Cash Flow | $-109 | $-463 | $-9 | $-9 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 8,010 | 44,111 | N/A | N/A | N/A |
| Debt Repayment | -2,844 | -5,498 | -2,779 | -1,111 | N/A |
| Common Stock Issued | 95 | 65 | 169,476 | 140,237 | 94,239 |
| Other Financing Activity | 0 | 13,616 | -284 | -284 | -219 |
| Financing Cash Flow | $5,261 | $52,294 | $166,413 | $138,842 | $94,020 |
| Beginning Cash Position | 11,409 | 30,158 | 153,765 | 153,765 | 153,765 |
| End Cash Position | 20,126 | 11,409 | 248,917 | 250,744 | 223,609 |
| Net Cash Flow | $8,717 | $-18,749 | $95,152 | $96,979 | $69,844 |
| Free Cash Flow | |||||
| Operating Cash Flow | 3,565 | -70,580 | -71,252 | -41,854 | -24,176 |
| Capital Expenditure | -109 | -463 | -9 | -9 | N/A |
| Free Cash Flow | 3,456 | -71,043 | -71,261 | -41,863 | -24,176 |